Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Terveystalo

7.81 EUR-1.51 %7.9, 10.55
12,315 following

TTALO

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor views
Compare
-1.51 %
+3.31 %
-4.76 %
-17.88 %
-20.14 %
-25.19 %
-0.38 %
-37.82 %
-21.90 %

Terveystalo operates in the healthcare sector. The company offers services and solutions such as surveys and examinations, training and coaching, rehabilitation, and health and fitness mapping. Its customers include small and medium-sized corporate customers, as well as public sector players. The head office is located in Helsinki.

Read more
Market cap
992.16M EUR
Turnover
573.05K EUR
P/E (adj.) (26e)
11.79
EV/EBIT (adj.) (26e)
12.08
P/B (26e)
1.72
EV/S (26e)
1.29
Dividend yield-% (26e)
3.84 %
Coverage
Recommendation
Reduce
Target price
7.60 EUR
Updated
20.07.2026
Disclaimer
Roni Peuranheimo
Roni Peuranheimo

Analyst

Latest research

Latest analysis report

Released: 20.07.2026

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
Terveystalo is making acquisitions again. Inderes Terveystalo vahvistaa kykyään tukea hyvinvointialueita ostamalla Solo Healthin... Terveystalo vahvistaa kykyään tukea hyvinvointialueita ostamalla Solo HealthinTerveystalo Oyj, lehdistötiedote 4.9.2026 klo 16.00Terveystalo Healthcare...
9/4/2026, 1:02 PM
by KuHa
22
Inside information, profit warning: Terveystalo lowers its earnings guidance for 2026 | Kauppalehti Terveystalo Oyj is lowering its earnings guidance for 2026. The lowering of the guidance reflects the challenging demand environment of the first half of the year and profitability...
7/15/2026, 12:37 PM
by Jukka
16
Here are Roni’s comments regarding the Finnish Competition and Consumer Authority’s (KKV) approval of the Hohde acquisition Terveystalo announced that the Finnish Competition and Consumer Authority (KKV) has approved the acquisition of Hohde Group announced in December 2025. As a...
9/4/2026, 4:49 AM
by Sijoittaja-alokas
15
Roni has published a new company report on Terveystalo. Terveystalo’s Q2 result did not contain any major surprises following the negative profit warning and preliminary data released ahead of the report. The still sluggish market, uncertainty regarding the value creation of future...
7/20/2026, 8:54 PM
by Sijoittaja-alokas
12
Didn’t the CEO say in the Roni interview that the market environment would be back to normal by Q4? Or am I misremembering…
7/15/2026, 2:22 PM
by Arvoansa1
12
Had to double-check this. Direct quote from the Q1 interview: “we expect relatively normal conditions through the end of the year.” You can check it out yourself in the Q1 interview starting from 11:30.
7/15/2026, 3:48 PM
by Arvoansa1
11
Inderes Kilpailu- ja kuluttajavirasto on hyväksynyt Hohde Groupin yritysoston... Kilpailu- ja kuluttajavirasto on hyväksynyt Hohde Groupin yritysoston Terveystalon antamin sitoumuksinTerveystalo Oyj, pörssitiedote 3.9.2026 klo 12.25Kilpailu- ja kuluttajavirasto (KKV) on ... Hohde...
9/3/2026, 10:56 AM
by supremegod
10
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7.10
2026

Half year dividend

21.10
2026

Interim report Q3'26

Nyt endnu flere opkøb fra Terveystalo
Analyst Comment07.09.2026, 07.05 by
Roni Peuranheimo

Nyt endnu flere opkøb fra Terveystalo

Opkøbet af Solo Health giver et betydeligt vækstboost til vikarbranchen.

Terveystalo
Press release04.09.2026, 15.00

Terveystalo strengthens its ability to support wellbeing services counties through the acquisition of Solo Health

Terveystalo
Regulatory press release04.09.2026, 14.40

Ville Pesonen appointed SVP, Oral Health and member of Terveystalo’s Executive Team

Terveystalo

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release04.09.2026, 14.35

Terveystalo to change its organisation and reporting structure in line with its updated strategy and operating model

Terveystalo
Regulatory press release04.09.2026, 14.30

Terveystalo completes the acquisition of Hohde Group

Terveystalo
Terveystalo har modtaget Konkurrence- og Forbrugermyndighedens godkendelse af Hohde-opkøbet mod lokale frasalg
Analyst Comment04.09.2026, 06.46 by
Roni Peuranheimo

Terveystalo har modtaget Konkurrence- og Forbrugermyndighedens godkendelse af Hohde-opkøbet mod lokale frasalg

Gennemførelsen af Hohde-handlen fordobler selskabets omsætning inden for mundsundhed.

Terveystalo
Regulatory press release03.09.2026, 11.25

Competition and Consumer Authority approves Terveystalo’s acquisition of Hohde Group subject to commitments

Terveystalo
Regulatory press release05.08.2026, 07.45

Sanna Ahonen appointed Terveystalo’s Chief Transformation Officer and member of Executive Team

Terveystalo
Terveystalo Q2'26: Indtjeningsvanskelighederne fortsætter
Research20.07.2026, 07.45 by
Roni Peuranheimo

Terveystalo Q2'26: Indtjeningsvanskelighederne fortsætter

Terveystalos Q2-regnskabsmeddelelse indeholdt ingen større overraskelser efter den negative nedjustering og de forudgående oplysninger, der blev givet før regnskabsmeddelelsen.

Terveystalo
Terveystalo, Webcast, Q2'26
Webcast17.07.2026, 09.30

Terveystalo, Webcast, Q2'26

Terveystalo
Regulatory press release17.07.2026, 08.00

Terveystalo Group Half-Year Report January–June 2026: Weak market conditions continued, actions taken to support profitability and growth

Terveystalo
Terveystalo sænkede sine forventninger på grund af svag efterspørgsel
Analyst Comment16.07.2026, 06.45 by
Roni Peuranheimo

Terveystalo sænkede sine forventninger på grund af svag efterspørgsel

Forventningerne til resultatet blev sænket til 120-140 MEUR på grund af skærpet priskonkurrence og svag efterspørgsel.

Terveystalo
Regulatory press release15.07.2026, 14.30

Inside information, profit warning: Terveystalo lowers its guidance for 2026

Terveystalo
Press release01.07.2026, 07.43

Terveystalo Half-Year 2026 result webcast and conference call on 17 July 2026

Terveystalo
Regulatory press release30.06.2026, 14.40

Terveystalo Oyj: Terveystalo Plc's Extraordinary General Meeting has approved the proposed resolution related to the acquisition of Silmäasema Oy

Terveystalo
Regulatory press release29.06.2026, 14.00

Change in Terveystalo’s Executive Team: Henri Mäenalanen to take up a new position outside the company

Terveystalo
Regulatory press release16.06.2026, 16.12

Terveystalo Plc increases bond maturing in 2028 by EUR 29.9 million and has submitted a listing application for the tap issue

Terveystalo
Terveystalo: Optikeren søger yderligere styrker
Research09.06.2026, 06.00 by
Roni Peuranheimo

Terveystalo: Optikeren søger yderligere styrker

Med opkøbene af Silmäasema og Hohde er Terveystalo ved at bevæge sig fra en stabil udbyttebetaler til en mere vækstorienteret retning.

Terveystalo
Terveystalo’s press conference on the Silmäasema acquisition
Webcast08.06.2026, 11.00

Terveystalo’s press conference on the Silmäasema acquisition

A briefing for investors and analysts will be held on 8 June 2026 at 12:00 noon EEST.

Terveystalo
Terveystalo køber Silmäasema og opdaterer sin strategi
Analyst Comment08.06.2026, 08.27 by
Roni Peuranheimo

Terveystalo køber Silmäasema og opdaterer sin strategi

Der er tale om et transformativt opkøb for Terveystalo.

Terveystalo